BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 22, 2018

View Archived Issues

Ionis licenses IONIS-AZ5-2.5Rx to AstraZeneca

Read More

Wave Life Sciences forms global CNS collaboration with Takeda

Read More

MSD and Viralytics enter definitive acquisition agreement to advance immuno-oncology pipeline

Read More

AbbVie announces topline results from phase III trial of elagolix for uterine fibroids

Read More

Evofem Biosciences' Amphora granted FDA fast track designation for prevention of chlamydia

Read More

Researchers discover OAT-2068, a highly selective and orally bioavailable inhibitor of mCHIT1

Read More

BioArctic receives approval to include Estonian patients in SC-0806 trial in spinal cord injury

Read More

First patient dosed in Centrexion's phase III trial of CNTX-4975 for moderate to severe knee OA pain

Read More

Medshine Discovery divulges new compounds for cytomegalovirus infection

Read More

Suzhou Guokuang Pharmtech, Hangzhou Adlai Nortye Pharmaceutical Technology patent IDO/TDO inhibitors

Read More

Novel SSAO inhibitors discovered at Lilly

Read More

Phase II data presented for RM-1929 photoimmunotherapy in patients with rHNSCC

Read More

Shenzhen Targetrx Biotechnology describes new HCV NS3/NS4A inhibitors

Read More

Erleada available to order in U.S. through Biologics

Read More

Phase IIa study of GWP-42006 in adults with focal seizures did not meet its primary endpoint

Read More

STA Pharmaceutical and Regulus sign oligonucleotide synthesis collaboration agreement

Read More

Phase III study of Mesoblast's remestemcel-L in acute GvHD meets primary endpoint

Read More

NIAID initiates phase I study of MERS-CoV antibodies REGN-3048 and REGN-3051

Read More

Endoscopic and symptom improvement seen with apremilast in phase II ulcerative colitis trial

Read More

EMA committee communicates positive trend vote for rucaparib

Read More

Vertex announces phase III study of VX-659, tezacaftor and ivacaftor for cystic fibrosis

Read More

TopiVert presents phase I data for TOP-1288 in healthy volunteers

Read More

Mouse model reveals role of the OTUD7A gene in 15q13.3 microdeletion syndrome

Read More

Tenofovir exalidex granted U.S. orphan designation for pediatric HBV infection

Read More

Tell us about your experience with TRDN

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing